Impact of Brokerage Rating on OraSure Technologies, Inc.(OSUR)

Many OraSure Technologies, Inc.(OSUR) Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock. OraSure Technologies was Upgraded by Raymond James to Outperform on Feb 9, 2017.

Company has reported several Insider transactions to the SEC, on Feb 13, 2017, Stephen S Phd Tang (director) sold 12,641 shares at 10.23 per share price.On Feb 13, 2017, Douglas A Michels (President & CEO) sold 193,355 shares at 10.21 per share price.On Feb 13, 2017, Mark L Kuna (SVP & Controller) sold 79,271 shares at 10.37 per share price.

OraSure Technologies Last issued its quarterly earnings results on Nov 2, 2016. The company reported $0.11 EPS for the quarter, beating the analyst consensus estimate by $ 0.04. Analyst had a consensus of $0.07. The company had revenue of $32.25 million for the quarter, compared to analysts expectations of $31.50 million. The companys revenue was up 7.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.03 EPS.

OraSure Technologies, Inc. (NASDAQ:OSUR) has received a short term rating of strong buy from experts at Zacks with a rank of 1. The stock has been rated an average of 1.5 by 4 Brokerage Firm. 2 Wall Street Firms have rated the stock as a strong buys. 2 stock experts have also suggested a buy rating.

OraSure Technologies, Inc. (NASDAQ:OSUR) shares are expected to touch $11.42 in the short term. This short term price target has been shared by 3 analysts. However, the standard deviation of short term price estimate has been valued at 0.52. The target price could hit $12 on the higher end and $11 on the lower end.

OraSure Technologies, Inc. (NASDAQ:OSUR) rose 3.53% or 0.37 points on Tuesday and made its way into the gainers of the day. After trading began at $10.4 the stock was seen hitting $10.87 as a peak level and $10.28 as the lowest level. The stock ended up at $10.86. The daily volume was measured at 1,086,044 shares. The 52-week high of the share price is $11.41 and the 52-week low is $5.57. The company has a market cap of $605 million.

OraSure Technologies, Inc. is the market leader for oral fluid diagnostics. The Company develops, manufactures, and markets medical devices and diagnostic products for use by insurance companies, public health agencies, clinical laboratories, physicians offices, and workplace sites.

OraSure

Share this post

Post Comment